Is Gabapentin safe for dogs and cats?
Low risk for petsGabapentin is used in dogs for adjunctive seizure management (typically alongside phenobarbital or potassium bromide) and as an analgesic for neuropathic pain, musculoskeletal pain, and postoperative pain. It is generally well-tolerated in dogs. The primary adverse effects are dose-dependent: sedation and ataxia are the most common, particularly at the higher end of the dosing range (5–30 mg/kg every 6–12 hours depending on indication). These CNS effects are managed by dose adjustment. Gabapentin is renally cleared — dose reduction is required in dogs with renal insufficiency. There is no significant hepatotoxicity concern in dogs, in contrast to phenobarbital. An important formulation safety note: gabapentin oral solution (e.g., 250 mg/5 mL Neurontin liquid) contains propylene glycol and/or xylitol in some commercial formulations — both are toxic to dogs (xylitol is profoundly toxic). Capsule and tablet formulations are preferred in veterinary use; liquid formulations must be checked for excipient content before use. Accidental high-dose ingestion causes prolonged sedation, ataxia, and hypothermia but is generally self-limiting with supportive care.
What is gabapentin?
The IUPAC name is 2-[1-(aminomethyl)cyclohexyl]acetic acid.
Also known as: 2-[1-(aminomethyl)cyclohexyl]acetic acid, Neurontin, Gabapentine, 1-(Aminomethyl)cyclohexaneacetic acid.
- IUPAC name
- 2-[1-(aminomethyl)cyclohexyl]acetic acid
- CAS number
- 60142-96-3
- Molecular formula
- C9H17NO2
- Molecular weight
- 171.24 g/mol
- SMILES
- C1CCC(CC1)(CC(=O)O)CN
- PubChem CID
- 3446
Risk for dogs
Low riskGabapentin is used in dogs for adjunctive seizure management (typically alongside phenobarbital or potassium bromide) and as an analgesic for neuropathic pain, musculoskeletal pain, and postoperative pain. It is generally well-tolerated in dogs. The primary adverse effects are dose-dependent: sedation and ataxia are the most common, particularly at the higher end of the dosing range (5–30 mg/kg every 6–12 hours depending on indication). These CNS effects are managed by dose adjustment. Gabapentin is renally cleared — dose reduction is required in dogs with renal insufficiency. There is no significant hepatotoxicity concern in dogs, in contrast to phenobarbital. An important formulation safety note: gabapentin oral solution (e.g., 250 mg/5 mL Neurontin liquid) contains propylene glycol and/or xylitol in some commercial formulations — both are toxic to dogs (xylitol is profoundly toxic). Capsule and tablet formulations are preferred in veterinary use; liquid formulations must be checked for excipient content before use. Accidental high-dose ingestion causes prolonged sedation, ataxia, and hypothermia but is generally self-limiting with supportive care.
Risk for cats
Low riskGabapentin is widely used in cats for pain management (neuropathic pain, osteoarthritis, postoperative pain), as an anxiolytic for veterinary visits and travel (pre-visit dosing is a common veterinary protocol — 50–100 mg orally 90 minutes before appointment), and for seizure management. Cats are more sensitive to gabapentin's sedative effects than dogs; doses producing mild sedation in dogs may cause pronounced sedation in cats, which is sometimes desirable for anxiolysis but requires dose titration for pain management. Adverse effects in cats are primarily dose-dependent sedation and ataxia. Renal clearance in cats means dose adjustment is needed with renal impairment. The xylitol/propylene glycol excipient concern with liquid formulations (critical for dogs) is also relevant for cats. Xylitol appears to be less acutely toxic in cats than in dogs, but propylene glycol is toxic to cats (causes oxidative damage to red blood cells). Only excipient-free formulations should be used in cats. Gabapentin is not a scheduled controlled substance (unlike pregabalin) but some states have placed it on monitoring programs.
Regulatory consensus
4 regulatory and scientific bodies have classified Gabapentin. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| FDA | — | Approved anticonvulsant (adjunctive therapy for partial-onset seizures) | FDA-approved indication |
| FDA | — | Approved analgesic (postherpetic neuralgia, diabetic neuropathy) | FDA-approved indication |
| FDA | 2019 | Respiratory depression risk warning | Warning issued regarding respiratory depression risk with gabapentin in patients with respiratory risk factors and CNS depressant co-administration |
| US States | — | Schedule V | Scheduled in several US states due to abuse potential |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where pets encounter gabapentin
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Gabapentin:
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is gabapentin safe for pets?
Gabapentin is used in dogs for adjunctive seizure management (typically alongside phenobarbital or potassium bromide) and as an analgesic for neuropathic pain, musculoskeletal pain, and postoperative pain. It is generally well-tolerated in dogs. The primary adverse effects are dose-dependent: sedation and ataxia are the most common, particularly at the higher end of the dosing range (5–30 mg/kg every 6–12 hours depending on indication). These CNS effects are managed by dose adjustment. Gabapentin is renally cleared — dose reduction is required in dogs with renal insufficiency. There is no significant hepatotoxicity concern in dogs, in contrast to phenobarbital. An important formulation safety note: gabapentin oral solution (e.g., 250 mg/5 mL Neurontin liquid) contains propylene glycol and/or xylitol in some commercial formulations — both are toxic to dogs (xylitol is profoundly toxic). Capsule and tablet formulations are preferred in veterinary use; liquid formulations must be checked for excipient content before use. Accidental high-dose ingestion causes prolonged sedation, ataxia, and hypothermia but is generally self-limiting with supportive care.
What products contain gabapentin?
Gabapentin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
Why do regulators disagree about gabapentin?
Gabapentin has been classified by 4 agencies including FDA, FDA, FDA, US States, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Gabapentin in the pets app
Look up products containing gabapentin, compare to alternatives, and explore the full data record.
Open in pets View raw API dataSources (3)
- US FDA: Gabapentin Prescribing Information — Indications, CNS Depression Warning, Respiratory Depression (2019 Drug Safety Communication), and Abuse Potential (2019) — regulatory
- ASPCA Animal Poison Control Center: Gabapentin Toxicosis in Dogs and Cats — Sedation, Ataxia, Excipient Concerns (Xylitol/Propylene Glycol), and Management (2023) — veterinary
- Plumb's Veterinary Drug Handbook (10th ed.) — Gabapentin: Veterinary Analgesia, Anxiolysis, Anticonvulsant Use, and Formulation Safety in Dogs and Cats (2023) — veterinary
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →